PT Changes

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler cut Salesforce Inc (NYSE:CRM) price target from $280 to $250. Piper Sandler analyst Billy...

Biomarin Pharmaceutical Inc (NASDAQ:BMRN) reported mixed results for the fourth quarter after the closing bell on Monday. The company posted quarterly earnings of 46 cents per share which missed the analyst consensus estimate of 63 cents per share. The company reported quarterly sales of $875.000...

Henry Schein Inc. (NYSE:HSIC) on Tuesday reported upbeat earnings for the fourth quarter. The company posted its fourth quarter adjusted earnings of $1.34, up from $1.19 a year ago, beating the consensus of $1.30. Sales totaled $3.44 billion, surpassing the consensus estimate of $3.35 billion. "Our...

Home Depot (NYSE:HD) reported upbeat earnings for the fourth quarter on Tuesday. The company posted quarterly earnings of $2.72 per share which beat the analyst consensus estimate of $2.54 per share. The company reported quarterly sales of $38.198 billion which beat the analyst consensus estimate...

CoStar Group Inc (NASDAQ:CSGP) reported upbeat fourth-quarter financial results and issued FY26 adjusted EPS guidance with its midpoint below estimates. CoStar reported quarterly earnings of 31 cents per share which beat the analyst consensus estimate of 27 cents per share. The company reported...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham cut Harmony Biosciences Holdings Inc (NASDAQ:HRMY) price target from $46 to $44. Needham analyst Ami...

CECO Environmental Corp (NASDAQ:CECO) on Tuesday reported worse-than-expected fourth-quarter adjusted EPS results and announced it will combine with Thermon Group Holdings. CECO Environmental reported quarterly earnings of 30 cents per share which missed the analyst consensus estimate of 39 cents...

Workday Inc. (NASDAQ:WDAY) on Tuesday posted upbeat fourth-quarter earnings but issued forward guidance below estimates. Workday reported quarterly earnings of $2.47 per share, which beat the Street estimate of $2.32. Quarterly revenue of $2.53 billion beat the consensus estimate of $2.52 billion...

EverQuote Inc (NASDAQ:EVER) reported better-than-expected earnings for the fourth quarter on Monday. The company posted quarterly earnings of 52 cents per share which beat the analyst consensus estimate of 46 cents per share. The company reported quarterly sales of $195.320 million which beat the...

Vir Biotechnology Inc. (NASDAQ:VIR) reported better-than-expected fourth-quarter earnings, anounced a significant strategic collaboration with Astellas Pharma Inc. (OTC:ALPMF) (OTC:ALPMY), and also disclosed early study results for VIR-5500. Vir Biotechnology reported a fourth-quarter loss of 31...

SGHC Ltd (NYSE:SGHC) reported better-than-expected fourth-quarter sales results and issued strong FY26 revenue guidance on Monday. Super Group reported quarterly sales of $578.300 million which beat the analyst consensus estimate of $518.328 million. SGHC said it sees FY2026 revenue to be more than...

Kratos Defense & Security Solutions Inc (NASDAQ:KTOS) on Monday reported upbeat financial results for the fourth quarter but issued first-quarter sales guidance below estimates. Revenue came in at $345.1 million, versus estimates of $327.79 million. Adjusted EPS came in at 18 cents, versus...

Hims & Hers Health Inc (NYSE:HIMS) reported mixed financial results for the fourth quarter after the market close on Monday. Hims & Hers Health reported fourth-quarter revenue of $617.82 million, missing analyst estimates of $619.22 million. The company reported fourth-quarter earnings of...

GeneDx Holdings Corp (NASDAQ:WGS) reported better-than-expected fourth-quarter financial results on Monday. GeneDx reported quarterly earnings of 14 cents per share which beat the analyst consensus estimate of 11 cents per share. The company reported quarterly sales of $120.989 million which beat...

Freshpet Inc. (NASDAQ:FRPT) posted mixed results for the fourth quarter on Monday. Net sales increased 8.6% to $285.2 million from $262.7 million a year earlier, driven by 9.7% volume growth and partially offset by a 1.1% unfavorable price/mix impact. Freshpet reported fourth-quarter earnings of 64...